Additional Programs

In conjunction with our core programs in cancer and cardiovascular disease, LIMR researchers also investigate arthritis, infectious disease, kidney failure, neurological disorders, and lung disease, with the goal of improving health and well-being.

At the Lankenau Institute for Medical Research, we have the distinct advantage of being located adjacent to Lankenau Medical Center, allowing researchers, nurses, and physicians to interact closely. In particular, this close proximity benefits our basic researchers who gain a more intimate understanding of clinical issues than generally gained at large academic medical centers. This influence helps promote research collaborations with hospital-based clinicians in gastroenterology, nephrology, pulmonology, endocrinology, neurology, obstetrics & gynecology, and nursing.

LIMR Faculty Involved in Additional Research Programs

Scott Dessain, MD, PhD (LIMR Center for Human Antibody Technology [CHAT]) – native human antibodies, mAb cloning, botulinum neurotoxin

Laura Mandik-Nayak, PhD – rheumatoid arthritis, immune regulation/suppression, autoimmune diseases

James M. Mullin, PhD – gastroenterology, tight junction, transepithelial permeability, gastrointestinal physiology, transport physiology, epithelial physiology, gastrointestinal cancer, epithelial barrier function

Melvin Reichman, PhD (LIMR Chemical Genomics Center) - drug discovery, high throughput screening, molecular pharmacology, chemical diversity

Main Line Health